'Welcome to mRNAge': Moderna Launches Campaign Touting the Potential of mRNA
Moderna is now pivoting its business strategy by using mRNA technology to address a range of respiratory diseases, including cancer, rare diseases, and cardiovascular diseases
Epoch Times , Bio and Archives--October 12, 2023
| Comments | Reader Friendly | Subscribe | Email Us
Biotechnology company and mRNA vaccine developer Moderna has launched a new campaign in Australia focussing on the “possibilities” of mRNA technology.
This comes as the biotech company and the Australian
government work to produce 100 million mRNA vaccine doses per year at a
soon-to-be-completed manufacturing facility in 2024. ---More...
View Comments
The Epoch Times: “A Fresh Look at Our Changing World”
The Epoch Times is a privately held news media company. The center is in New York, but our network of local reporters throughout the world uncovers stories that are authentically local, yet also globally relevant. Our independence enables us to report widely and present a diversity of opinions.
We have offices in 30 countries across five continents, and our content is published in 17 languages. We are proud to offer print and web editions in Chinese, English, German, French, Spanish, Hebrew, Russian, Japanese, Korean and Indonesian, as well as web versions in Ukrainian, Bulgarian, Romanian, Czech, Slovak, Vietnamese and Swedish.